Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice

Phytotherapy Research

Volumn 25, Issue 6, 2011, Pages 789-795

  Sampath, C ^a   Holbik, M ^b   Krenn, L ^b   Butterweck, V ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

anxiolytic effect; benzodiazepines; elevated plus maze; locomotor activity; Passiflora incarnata; Passifloraceae

Indexed keywords

BENZOFLAVONE DERIVATIVE; BUTANOL; CHLOROFORM; DIAZEPAM; PASSIFLORA INCARNATA EXTRACT; PETROLEUM ETHER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG ISOLATION; FRACTIONATION; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PHYTOCHEMISTRY; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PASSIFLORA; PLANT EXTRACTS;

ANIMALIA; MUS; PASSIFLORA; PASSIFLORA INCARNATA; PASSIFLORACEAE;

EID: 79957860098     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3332     Document Type: Article

References (32)

1. Anke J, Ramzan I,. 2004. Kava hepatotoxicity: Are we any closer to the truth? Planta Med 70: 193-196. (Pubitemid 38445182)
2. Bergner P., 1995. Passionflower. Medical Herbalism 7: 13-14.
3. Buchbauer G, Jirovetz L, Jager W,. 1992. Passiflora and lime-blossoms: motility effects after inhalation of the essential oils and of some of the main constituents in animal experiment. Arch Pharm (Weinheim) 325: 247-248.
4. Coleta M, Batista MT, Campos MG, et al. 2006. Neuropharmacological evaluation of the putative anxiolytic effects of Passiflora edulis Sims, its sub-fractions and flavonoid constituents. Phytother Res 20: 1067-1073. (Pubitemid 44951711)
5. Congora C, Proliac A, Raynaud J,. 1986. Isolation and identification of two new mono-C-glycosyl luteolins and of the di-substituted 6,8-diglucosyl luteolin from the leafy stalks of Passiflora incarnata L. Helv Chim Acta 69: 251-253.
6. Dawson GR, Tricklebank MD,. 1995. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16: 33-36.
7. Deng J, Zhou Y, Bai M, Li H, Li L,. 2010. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa. J Ethnopharmacol 128: 148-153.
8. Devane CL, Chiao E, Franklin M, Kruep EJ,. 2005. Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression. Am J Manag Care 11: S344-S353. (Pubitemid 41546875)
9. Dhawan K, Kumar S, Sharma A,. 2001. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J Ethnopharmacol 78: 165-170. (Pubitemid 32994786)
10. Ernst E., 2006. Herbal remedies for anxiety-a systematic review of controlled clinical trials. Phytomedicine 13: 205-208. (Pubitemid 43120323)
11. Gaudiano BA, Miller IW,. 2005. Anxiety disorder co-morbidity in Bipolar I Disorder: relationship to depression severity and treatment outcome. Depress Anxiety 21: 71-77. (Pubitemid 40734022)
12. Grandolini G, Ambrogi V, Perioli L, D'Eramo D, Bernardini C, Giampietri A., 1997. Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. XI. Synthesis and biological activity of several naphtho- and quinolino-1,4-thiazine and -1,4-thiazepine derivatives containing the imidazole ring. Farmaco 52: 379-384. (Pubitemid 27479490)
13. Grundmann O, Waehling C, Staiger C, Butterweck V,. 2009. Anxiolytic effects of a passion flower (Passiflora incarnata L.) extract in the elevated plus maze in mice. Pharmazie 64: 63-64.
14. Grundmann O, Wang J, McGregor GP, Butterweck V., 2008. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta Med 74: 1769-1773.
15. Holbik M,. 2010. Chemische Untersuchungen des Passionsblumenkrautextraktes KY 705 P. Diploma thesis, University of Vienna.
16. Holbik M, Krasteva S, Mayer N, Kahlig H, Krenn L,. 2010. Apparently no sedative benzoflavone moiety in passiflorae herba. Planta Med 76: 662-664.
17. Krenn L,. 2002. Passion flower (Passiflora incarnata L.) a reliable herbal sedative. Wien Med Wochenschr 152: 404-406. (Pubitemid 34984933)
18. Krenn L,. 2006. Aktuelles über Passiflora incarnata. Z Phytother 27: 47-50.
19. Kunovac JL, Stahl SM,. 1995. Future directions in anxiolytic pharmacotherapy. Psychiatr Clin North Am 18: 895-909. (Pubitemid 26001316)
20. Lader M, Morton S,. 1991. Benzodiazepine problems. Br J Addict 86: 823-828.
21. Lutomski J, Segiet E, Szpunar K, Grisse K,. 1981. The importance of the passionflower in medicine. Pharm Unserer Zeit 10: 45-49.
22. Marchart E, Krenn L, Kopp B,. 2003. Quantification of the flavonoid glycosides in Passiflora incarnata by capillary electrophoresis. Planta Med 69: 452-456. (Pubitemid 36774187)
23. Pellow S, Chopin P, File SE, Briley M,. 1985. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167. (Pubitemid 16239568)
24. Poethke W, Schwarz C, Gerlach H,. 1970. Components of Passiflora bryonioides. 2. Flavone derivatives. Planta Med 19: 177-188.
25. Rehwald A, Sticher O, Meier B,. 1995. Trace analysis of harman alkaloids in Passiflora incarnata by reversed-phase high performance liquid chromatography. Phytochem Anal 6: 96-100. (Pubitemid 26124096)
26. Sena LM, Zucolotto SM, Reginatto FH, Schenkel EP, De Lima TC,. 2009. Neuropharmacological activity of the pericarp of Passiflora edulis flavicarpa degener: putative involvement of C-glycosylflavonoids. Exp Biol Med 234: 967-975.
27. Shimada T, Matsumoto K, Osanai M, Matsuda H, Terasawa K, Watanabe H,. 1995. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 26: 205-210.
28. Spencer KC, Seigler DS,. 1984. Gynocardin from passiflora. Planta Med 50: 356-357. (Pubitemid 14008721)
29. Tsuchiya H, Hayashi H, Sato M, Shimizu H, Iinuma M,. 1999a. Quantitative analysis of all types of β-carboline alkaloids in medicinal plants and dried edible plants by high performance liquid chromatography with selective fluorometric detection. Phytochem Anal 10: 247-253. (Pubitemid 29450349)
30. Tsuchiya H, Shimizu H, Iinuma M,. 1999b. Beta-carboline alkaloids in crude drugs. Chem Pharm Bull 47: 440-443. (Pubitemid 29166292)
31. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH,. 1994. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 47: 1-4.
32. Zhang ZJ,. 2004. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75: 1659-1699.